Dan Edwall
Directeur Général chez Doktor Edwall AB
Profil
Dan Edwall is currently the Chief Executive Officer at Doktor Edwall AB, Chairman at BioFood Medica AB, and Vice President-Research & Development at Scandivir AB.
He previously worked as Vice President-Research & Development at Nimutan AB and NattoPharma ASA. Dr. Edwall holds a doctorate degree from Karolinska Institutet.
Postes actifs de Dan Edwall
| Sociétés | Poste | Début |
|---|---|---|
| BioFood Medica AB | Président | 01/07/2011 |
| Doktor Edwall AB | Directeur Général | 01/07/2011 |
| Scandivir AB | Directeur Technique/Scientifique/R&D | 01/07/2011 |
Anciens postes connus de Dan Edwall
| Sociétés | Poste | Fin |
|---|---|---|
| NIMUTAN AB (PUBL) | Directeur Technique/Scientifique/R&D | - |
| NATTOPHARMA ASA | Directeur Technique/Scientifique/R&D | - |
Formation de Dan Edwall
| Karolinska Institutet | Doctorate Degree |
Expériences
Fonctions occupées
Sociétés liées
| Entreprise privées | 5 |
|---|---|
Nimutan AB
 Nimutan AB Household/Personal CareConsumer Non-Durables Nimutan AB engages in the development, marketing, and sale of nutritional products and food supplements. It operates through the following segments: Brand Sales; Production, Innovation, and Private Label; and Corporate. It sells a variety of products for men and women's health, joint health, and skin care. The company was founded by Bengt Johansson on November 15, 2005 and is headquartered in Jönköping, Sweden. | Consumer Non-Durables |
NattoPharma ASA
 NattoPharma ASA Pharmaceuticals: MajorHealth Technology NattoPharma ASA engages in the manufacture and sale of nutritional and pharmaceutical products. It offers vitamin K2 under the product brand MenaQ7. The company was founded by Frode Marc Bohan on November 4, 2004 and is headquartered in Oslo, Norway. | Health Technology |
| Scandivir AB | |
| BioFood Medica AB | |
| Doktor Edwall AB |
